BioSpace News Archive

Drug Development

Alnylam to Present Full 18-Month Results from the HELIOS-A Phase 3 Study of Vutrisiran at the Société Francophone du Nerf Périphérique Annual Meeting

Alnylam Pharmaceuticals, Inc. announced today that the Company will present full 18-month results from the HELIOS-A Phase 3 study of vutrisiran.

January 14, 2022
·
9 min read
FDA

Glenmark Specialty S.A. (Switzerland) receives NDA Approval by the United States Food and Drug Administration (FDA) for Ryaltris™ Nasal Spray

Ryaltris™ is a metered, fixed-dose, aqueous suspension, prescription drug product nasal spray approved by the FDA for the treatment of symptoms of Seasonal Allergic Rhinitis in adults and pediatric patients 12 years of age and older.

January 14, 2022
·
4 min read
Drug Development

Pieris Pharmaceuticals Announces Dosing of First Patient in Phase 2 Gastric Cancer Trial of 4–1BB/HER2 Bispecific Cinrebafusp Alfa

Pieris Pharmaceuticals, Inc. today announced that the first patient has been dosed in the phase 2 study of cinrebafusp alfa (PRS-343), a 4-1BB/HER2 Anticalin-based bispecific for the treatment of HER2-expressing gastric cancer.

January 14, 2022
·
5 min read
Biotech Beach

Vivera Pharmaceuticals Issues Statement Regarding LuSys Laboratories COVID-19 Tests

Vivera Pharmaceuticals is highly discouraged to read the latest FDA safety communication that erroneously lists Vivera Pharmaceuticals as a brand of LuSys Laboratories or as a distributor of the LuSys Eagle Diagnostics test.

January 14, 2022
·
1 min read
Business

ENVI and GreenLight Biosciences Announce Filing of Definitive Proxy Statement/Prospectus and the February 1st, 2022 Special Meeting to Approve Proposed Business Combination

Environmental Impact Acquisition Corporation announced today that ENVI’s definitive proxy statement/prospectus (the “Proxy Statement”) relating to the previously announced business combination with GreenLight Biosciences, Inc.

January 14, 2022
·
7 min read
Medical Supplies Market Size to Reach USD 189.03 Billion in 2028 Growing at a CAGR of 4.5%

According to Emergen Research, the global medical supplies market size was USD 132.26 billion in 2020 and is expected to reach USD 189.03 billion in 2028 and register a revenue CAGR of 4.5% during the forecast period, 2021-2028.

January 14, 2022
·
8 min read
Surgical Instrument Tracking Systems Market Size to Reach USD 488.57 Million in 2028 Growing at a CAGR of 13.2%, According to Emergen Research

According to Emergen Research, the global surgical instrument tracking systems market size was USD 180.44 million in 2020 and is expected to reach USD 488.57 million in 2028 and register a revenue CAGR of 13.2% during the forecast period, 2021-2028.

January 14, 2022
·
7 min read
Drug Discovery Informatics Market To Reach USD 4.09 Billion By 2027, Says Reports And Data

Rising prevalence of chronic diseases and increasing investment in research & development are key factors driving growth of the drug discovery informatics market.

January 14, 2022
·
7 min read
Membrane Chromatography Market To Reach USD 641.87 Million By 2028, Says Reports And Data

Increasing investment in biopharmaceutical R&D, rising demand for membrane chromatography in pharmaceutical drug analysis processes, and advantages of membrane chromatography over conventional chromatography processes are key factors driving revenue growth of the market.

January 14, 2022
·
8 min read
Proteomics Market To Reach USD 65.91 By 2028, Says Reports And Data

Growing trend of personalized medicine is a key factor projected to support growth of proteomics market.

January 14, 2022
·
7 min read